- Home
- RPRX vs NVT Comparison
RPRX vs NVT Comparison
Compare RPRX & NVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RPRX | NVT |
|---|---|---|
| Founded | 1996 | 1903 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 22.0B | 21.7B |
| IPO Year | 2020 | 2017 |
Fundamental Metrics
Financial Performance| Metric | RPRX | NVT |
|---|---|---|
| Price | $52.97 | $169.40 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 11 |
| Target Price | $51.40 | ★ $131.36 |
| AVG Volume (30 Days) | ★ 2.8M | 2.1M |
| Earning Date | 05-06-2026 | 05-01-2026 |
| Dividend Yield | ★ 1.90% | 0.61% |
| EPS Growth | N/A | ★ 118.78 |
| EPS | 0.67 | ★ 0.87 |
| Revenue | $2,378,193,000.00 | ★ $3,893,100,000.00 |
| Revenue This Year | $38.63 | $19.44 |
| Revenue Next Year | $4.73 | $12.41 |
| P/E Ratio | ★ $79.66 | $199.67 |
| Revenue Growth | 5.06 | ★ 29.51 |
| 52 Week Low | $32.15 | $63.15 |
| 52 Week High | $53.47 | $175.00 |
Technical Indicators
Market Signals| Indicator | RPRX | NVT |
|---|---|---|
| Relative Strength Index (RSI) | 68.50 | 67.66 |
| Support Level | $35.35 | $92.46 |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 1.08 | 6.00 |
| MACD | 0.21 | 0.67 |
| Stochastic Oscillator | 81.19 | 85.31 |
Price Performance
Historical ComparisonAbout RPRX Royalty Pharma plc
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.
About NVT nVent Electric plc
NVent is a leading global provider of electrical connection and protection solutions that touch a broad range of end markets, including infrastructure, industrial, commercial, and residential. NVent designs, manufactures, markets, installs, and services a portfolio of electrical enclosures and electrical fastening solutions. North America accounts for the majority of sales.